Premium
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19
Author(s) -
Spyropoulos Alex C.,
Levy Jerrold H.,
Ageno Walter,
Connors Jean Marie,
Hunt Beverley J.,
Iba Toshiaki,
Levi Marcel,
Samama Charles Marc,
Thachil Jecko,
Giannis Dimitrios,
Douketis James D.
Publication year - 2020
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.14929
Subject(s) - medicine , covid-19 , venous thromboembolism , pandemic , intensive care medicine , disease , coronavirus , diagnostic test , medline , emergency medicine , infectious disease (medical specialty) , thrombosis , pathology , outbreak , political science , law
The novel coronavirus disease of 2019 (COVID-19) pandemic, as declared by the World Health Organization, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Cardiovascular disease and, in particular, venous thromboembolism (VTE) has emerged as an important consideration in the management of hospitalized patients with COVID-19. The diagnosis of VTE using standardized objective testing is problematic in these patients, given the risk of infecting non-COVID-19 hospitalized patients and hospital personnel, coupled with the usual challenges of performing diagnostic testing in critically-ill patients. Early reports suggest a high incidence of VTE in hospitalized COVID-19 patients, particularly those with severe illness, that is similar to the high VTE rates observed in patients with other viral pneumonias, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS-CoV).